Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Immuron Limited ( (AU:IMC) ) has issued an update.
Immuron Limited has announced a proposed issue of 45,472,000 ordinary fully paid securities, with the issue date set for December 5, 2025. This move is part of a placement or other type of issue, which could potentially impact the company’s market positioning by increasing its capital base and providing additional resources for its operations.
The most recent analyst rating on (AU:IMC) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Immuron Limited stock, see the AU:IMC Stock Forecast page.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases.
Average Trading Volume: 573,162
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$18.34M
See more data about IMC stock on TipRanks’ Stock Analysis page.